EQT
50
-4
LB
42
-6
NWS
46
-2
HPE
64
-5
FCX
74
-2
KR
32
2
KO
46
5
WYNN
34
-3
CAT
70
-9
CMI
72
-5
LRCX
53
-8
URI
46
-4
EQIX
50
-3
KMI
57
-4
FE
50
-2
ZION
68
-3
NTAP
60
-6
UHS
60
-3
RSG
51
3
ABT
41
3
EQT
50
-4
LB
42
-6
NWS
46
-2
HPE
64
-5
FCX
74
-2
KR
32
2
KO
46
5
WYNN
34
-3
CAT
70
-9
CMI
72
-5
LRCX
53
-8
URI
46
-4
EQIX
50
-3
KMI
57
-4
FE
50
-2
ZION
68
-3
NTAP
60
-6
UHS
60
-3
RSG
51
3
ABT
41
3
Financhill
Back

SPDR S&P Global Natural Resources ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
51

GNR
SPDR S&P Global Natural Resources ETF

Last Price:
$61.92
Seasonality Move:
1.06%
Sell
46

CRSP
CRISPR Therapeutics AG

Last Price:
$56.74
Seasonality Move:
16.15%
Buy
51
SPDR S&P Global Natural Resources ETF (GNR) is a Buy

Is SPDR S&P Global Natural Resources ETF a Buy, Sell or Hold?

  • The current SPDR S&P Global Natural Resources ETF [GNR] share price is $62.31. The Score for GNR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • GNR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $56.68. The Score for CRSP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GNR Stock Price Chart

What is SPDR S&P Global Natural Resources ETF's stock price today?

  • The SPDR S&P Global Natural Resources ETF share price today is $62.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GNR is experiencing slight selling pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $56.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.

GNR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 63.22 Buy
Chaikin Money Flow: -25057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.34 - 61.66) Buy
Bollinger Bands (100): (56.64 - 60.3) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 50.79 Buy
Chaikin Money Flow: -310612 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.51 - 56.73) Buy
Bollinger Bands (100): (52.75 - 65.77) Sell

GNR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.74 Buy
20-day SMA: 60.6 Buy
50-day SMA: 59.71 Buy
200-day SMA: 55.74 Buy
8-day EMA: 61.71 Buy
20-day EMA: 60.91 Buy
50-day EMA: 58.68 Buy
200-day EMA: 36.39 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.23 Sell
20-day SMA: 54.24 Buy
50-day SMA: 60.61 Sell
200-day SMA: 50.79 Buy
8-day EMA: 56.62 Buy
20-day EMA: 55.98 Buy
50-day EMA: 56.55 Buy
200-day EMA: 36.64 Buy

SPDR S&P Global Natural Resources ETF Earnings Growth & GNR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

SPDR S&P Global Natural Resources ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):